Profile
José Vicente Pons Andreu served as the Chief Executive Officer of Curapath & Expansion of Drug Delivery Capabilities & Services.
He also worked as a Director at Natraceutical SA from 2000 to 2012.
Former positions of José Vicente Pons Andreu
| Companies | Position | End |
|---|---|---|
Natraceutical SA
 Natraceutical SA Food: Major DiversifiedConsumer Non-Durables Natraceutical SA engages in the research and development of naturally-sourced functional/active ingredients and nutritional complements for the foodstuffs, pharmaceutical and cosmetics sectors. It streamlines its industrial activity through two divisions, the Ingredients Division and the Nutritional Supplements Division, with the purpose of contributing to the prevention of diseases and improving quality of life through nutrition. It was founded on June 1, 1993 and is headquartered in Valencia, Spain. | Director/Board Member | - |
Curapath & Expansion of Drug Delivery Capabilities & Services
 Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Natraceutical SA
Natraceutical SA Food: Major DiversifiedConsumer Non-Durables Natraceutical SA engages in the research and development of naturally-sourced functional/active ingredients and nutritional complements for the foodstuffs, pharmaceutical and cosmetics sectors. It streamlines its industrial activity through two divisions, the Ingredients Division and the Nutritional Supplements Division, with the purpose of contributing to the prevention of diseases and improving quality of life through nutrition. It was founded on June 1, 1993 and is headquartered in Valencia, Spain. | Consumer Non-Durables |
Curapath & Expansion of Drug Delivery Capabilities & Services
Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021. | Health Technology |
- Stock Market
- Insiders
- José Vicente Pons Andreu